bcl-2 Protein is increased in the brain from parkinsonian patients

Neuroscience Letters

Volumn 215, Issue 2, 1996, Pages 137-139

  Mogi, Makio ^a   Harada, Minoru ^a   Kondo, Tomoyoshi ^b   Mizuno, Yoshikuni ^b   Narabayashi, Hirotaro ^b   Riederer, Peter ^c   Nagatsu, Toshiharu ^d  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

bcl 2; Brain; Parkinson's disease

Indexed keywords

ONCOPROTEIN; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; APOPTOSIS; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0030572714     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12961-X     Document Type: Article

References (30)

1. [1] Akao, Y., Otsuki, Y., Kataoka, S., Ito, Y. and Tsujimoto, Y., Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane and mitochondrial membranes, Cancer Res., 54 (1994) 2468-2471.
2. [2] Allsopp, T.E., Wyatt, S., Paterson, H.F. and Davies, A.M., The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis, Cell. 73 (1993) 295-307.
3. [3] Araujo, D.M. and Lapchak, P.A., Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience, 61 (1994) 745-754.
4. [4] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding, Anal. Biochem., 72 (1976) 248-254.
5. [5] Dipasquale, B., Marini, A.M. and Youle, R.J., Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem. Biophys. Res. Commun., 181 (1991) 1442-1448.
6. [6] Fahn, S. and Cohen, G., The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol., 32 (1992) 804-812.
7. [7] Fiszer, U., Piotrowska, K., Korlak, J. and Czlonkowska, A., The immunological status in Parkinson's disease. Med. Lab. Sci. 48 (1991) 196-200.
8. [8] Garcia, I., Martinou, L. Tsujimoto, Y. and Martinou, J.-C., Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science, 258 (1992) 302-304.
9. [9] Hengartner, M.O. and Horvitz, H.R., C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 76 (1994) 665-676.
10. [10] Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. and Korsmeyer, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348 (1990) 334-336.
11. [11] Hockenbery, D.M., Zutter, M., Mickey, W., Nahm, M. and Korsmeyer, S.J., Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88 (1991) 6961-6965.
12. [12] Hockenbery, D.M., Oltvai, Z.N., Yin, X.-M., Milliman, C.L. and Korsmeyer, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell. 75 (1993) 241-251.
13. [13] Jenner, P., Oxidative damage in neurodegenerative disease. Lancet. 344 (1994) 796-798.
14. [14] Kane, D.J., Sarafian, T.A., Anton, R., Hahn, H., Gralla, E.B., Valentine, J.S., Ord, T. and Bredesen, D.E., Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science, 262 (1993) 1274-1277.
15. [15] Korsmeyer, S.J., Bcl-2: an antidote to programmed cell death. Cancer Surv., 15 (1992) 105-118.
16. [16] LeBrun, D.P., Warnke, R.A. and Cleary, M.L., Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am. J. Pathol., 142 (1993) 743-753.
17. [17] Marttila, R.J., Eskola, J., Paivarinta, M. and Rinne, U.K., Immune functions in Parkinson's disease. Adv. Neurol., 40 (1984) 315-323.
18. [18] Migheli, A., Cavalla, P., Piva, R., Giordana, M.T. and Schiffer, D., bcl-2 Protein expression in aged brain and neurodegenerative diseases, NeuroReport, 5 (1994) 1906-1908.
19. [19] Mochizuki, H., Akiyama, H., Srajewski, S., Reed, J.C. and Mizuno, Y., Bcl-2 expression in degenerative neurological disease, Movement Disorders, 11 (Suppl. 1)(1996) 186.
20. [20] Mochizuki, H., Goto, K., Hideo, M. and Mizuno, Y., Histochemical detection of apoptosis in Parkinson's disease, J. Neurol. Sci., 137 (1996) 120-123.
21. [21] Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K. and Nagatsu, T., Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients, Neurosci. Lett., 165 (1994) 208-210.
22. [22] Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M. and Nagatsu, T., Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients, Neurosci. Lett., 180 (1994) 147-150.
23. [23] Mogi, M., Harada, M., Kondo, T., Riederer, P. and Nagatsu, T., Brain β2-microglobulin levels are elevated in the striatum in Parkinson's disease, J. Neural Transm. (P.-D. Sect.), 9 (1995) 87-92.
24. [24] Mogi, M., Harada, M., Kondo, T., Narabayashi, H., Riederer, P. and Nagatsu, T., Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease, Neurosci. Lett., 193 (1995) 129-132.
25. [25] O'barr, S., Schultz, J. and Rogers, J., Expression of the protooncogene bcl-2 in Alzheimer's disease brain, Neurobiol. Aging, 17 (1996) 131-136.
26. [26] Pouplard, A. and Emile, J., Autoimmunity in Parkinson's disease, Adv. Neurol., 40 (1984) 307-313.
27. [27] Satou, T., Cummings, B.J. and Cotman, C.W., Immunoreactivity for bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity, Brain Res., 697 (1995) 35-43.
28. [28] Sternberg, E.M., Monokines, lymphokines and the brain. In J.M. Cruse and R.E. Lewis, Jr. (Eds.), The Years in Immunology 1988: Immunoregulatory Cytokines and Cell Growth, Karger, Basal, 1988, pp. 205-217.
29. [29] Tsujimoto, Y. and Croce, C.M., Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma, Proc. Natl. Acad. Sci. USA. 83 (1986) 5214-5218.
30. [30] Wood, J.A., Wood, P.L., Ryan, R., Graff-Radford, N.R., Pilapil, C., Robitaille, Y. and Quirion, R., Cytokine induces in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins 1L-6, α2-macroglobulin and C-reactive protein. Brain Res., 629 (1993) 245-252.